A-1331852 0.65mL

A-1331852 0.65mLA 1331852 is a potent and selectiveBCL XL inhibitor with Ki value less than 0. 01 nM for BCL XL and 6 nM, 4 nM, 142 nM for Bcl 2, Bcl W, MCL 1 respectively. It may be useful in the treatment of cancer, immune and autoimmune diseases.

L-cysteine Hydrochloride

is converted to NAD+ by nicotinamide mononucleotide adenylyltransferase

(73 nM) and little active to PKC

1 nM and 12

Chlorprothixene has strong binding affinities to dopamine and histamine receptors

Bcr-Abl and InsR

Nazartinib (EGF816

being important in industry with a peachy aroma

2Micrometer Pore Surfactant Free Cellulose Acetate Membrane with prefilter

ELR-510444 is a novel microtubule disruptor with potential antivascular effects and in vivo antitumor efficacy

Robust platform made of stainless steel and high ingress protection allows to operate the scale in a moist environment and at direct contact with water (e

Factor XII) and causes inhibition of its coagulant properties